• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

pH 依赖性结合工程揭示了一个控制 IgG 循环的 FcRn 亲和力阈值。

pH-dependent binding engineering reveals an FcRn affinity threshold that governs IgG recycling.

作者信息

Borrok M Jack, Wu Yanli, Beyaz Nurten, Yu Xiang-Qing, Oganesyan Vaheh, Dall'Acqua William F, Tsui Ping

机构信息

From the Departments of Antibody Discovery and Protein Engineering and.

Clinical Pharmacology and Drug Metabolism and Pharmacokinetics, MedImmune, Inc., Gaithersburg, Maryland 20878.

出版信息

J Biol Chem. 2015 Feb 13;290(7):4282-90. doi: 10.1074/jbc.M114.603712. Epub 2014 Dec 23.

DOI:10.1074/jbc.M114.603712
PMID:25538249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4326836/
Abstract

The Fc domain of IgG has been the target of multiple mutational studies aimed at altering the pH-dependent IgG/FcRn interaction to modulate IgG pharmacokinetics. These studies have yielded antibody variants with disparate pharmacokinetic characteristics, ranging from extended in vivo half-life to those exhibiting extremely rapid clearance. To better understand pH-dependent binding parameters that govern these outcomes and limit FcRn-mediated half-life extension, we generated a panel of novel Fc variants with high affinity binding at acidic pH that vary in pH 7.4 affinities and assessed pharmacokinetic outcomes. Pharmacokinetic studies in human FcRn transgenic mice and cynomolgus monkeys showed that multiple variants with increased FcRn affinities at acidic pH exhibited extended serum half-lives relative to the parental IgG. Importantly, the results reveal an underappreciated affinity threshold of neutral pH binding that determines IgG recycling efficiency. Variants with pH 7.4 FcRn affinities below this threshold recycle efficiently and can exhibit increased serum persistence. Increasing neutral pH FcRn affinity beyond this threshold reduced serum persistence by offsetting the benefits of increased pH 6.0 binding. Ultra-high affinity binding to FcRn at both acidic and neutral pH leads to rapid serum clearance.

摘要

IgG的Fc结构域一直是多项突变研究的目标,这些研究旨在改变pH依赖性的IgG/FcRn相互作用,以调节IgG的药代动力学。这些研究产生了具有不同药代动力学特征的抗体变体,从延长的体内半衰期到表现出极快清除率的变体。为了更好地理解控制这些结果并限制FcRn介导的半衰期延长的pH依赖性结合参数,我们生成了一组在酸性pH下具有高亲和力结合的新型Fc变体,它们在pH 7.4亲和力方面有所不同,并评估了药代动力学结果。在人FcRn转基因小鼠和食蟹猴中的药代动力学研究表明,与亲本IgG相比,多个在酸性pH下具有增加的FcRn亲和力的变体表现出延长的血清半衰期。重要的是,结果揭示了一个未被充分认识的中性pH结合亲和力阈值,该阈值决定了IgG的循环效率。在pH 7.4时FcRn亲和力低于该阈值的变体能够有效循环,并可表现出血清持久性增加。将中性pH下的FcRn亲和力提高到超过该阈值会抵消pH 6.0结合增加的益处,从而降低血清持久性。在酸性和中性pH下与FcRn的超高亲和力结合会导致血清快速清除。

相似文献

1
pH-dependent binding engineering reveals an FcRn affinity threshold that governs IgG recycling.pH 依赖性结合工程揭示了一个控制 IgG 循环的 FcRn 亲和力阈值。
J Biol Chem. 2015 Feb 13;290(7):4282-90. doi: 10.1074/jbc.M114.603712. Epub 2014 Dec 23.
2
Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody.糖基化和蛋白质-Fc联合工程同时增强治疗性抗体的细胞毒性和半衰期。
MAbs. 2014 Mar-Apr;6(2):422-36. doi: 10.4161/mabs.27854. Epub 2014 Jan 15.
3
Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.新生儿 FcR 在调节含有人 IgG1 Fc 结构域的治疗性蛋白血清半衰期中的重要性:单克隆抗体和 Fc 融合蛋白与人新生儿 FcR 亲和力的比较研究。
J Immunol. 2010 Feb 15;184(4):1968-76. doi: 10.4049/jimmunol.0903296. Epub 2010 Jan 18.
4
Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-life.抗体 Fc 工程改造增强新生儿 Fc 受体结合和延长循环半衰期。
MAbs. 2019 Oct;11(7):1276-1288. doi: 10.1080/19420862.2019.1633883. Epub 2019 Jul 18.
5
Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics.抗体可变结构域对FcRn依赖性药代动力学的电荷介导影响。
Proc Natl Acad Sci U S A. 2015 May 12;112(19):5997-6002. doi: 10.1073/pnas.1408766112. Epub 2015 Apr 27.
6
A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodies.一种研究甲硫氨酸氧化对治疗性抗体药代动力学特性影响的新方法。
MAbs. 2014;6(5):1229-42. doi: 10.4161/mabs.29601. Epub 2014 Oct 30.
7
Engineering human IgG1 affinity to human neonatal Fc receptor: impact of affinity improvement on pharmacokinetics in primates.工程化人IgG1对人新生儿Fc受体的亲和力:亲和力提高对灵长类动物药代动力学的影响。
J Immunol. 2009 Jun 15;182(12):7663-71. doi: 10.4049/jimmunol.0804182.
8
The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity.新生儿Fc受体(FcRn)以相同的亲和力独立结合至IgG同型二聚体的两个位点。
MAbs. 2015;7(2):331-43. doi: 10.1080/19420862.2015.1008353.
9
Monoclonal antibody clearance. Impact of modulating the interaction of IgG with the neonatal Fc receptor.单克隆抗体清除率。调节IgG与新生儿Fc受体相互作用的影响。
J Biol Chem. 2007 Jan 19;282(3):1709-17. doi: 10.1074/jbc.M607161200. Epub 2006 Nov 29.
10
Pharmacokinetics of humanized monoclonal anti-tumor necrosis factor-{alpha} antibody and its neonatal Fc receptor variants in mice and cynomolgus monkeys.在小鼠和食蟹猴中,人源化单克隆抗肿瘤坏死因子-α 抗体及其新生儿 Fc 受体变体的药代动力学研究。
Drug Metab Dispos. 2010 Apr;38(4):600-5. doi: 10.1124/dmd.109.031310. Epub 2010 Jan 13.

引用本文的文献

1
Model-Informed Optimal Dosing of Anti-CD47 Antibody Using Target-Mediated Drug Disposition Model.使用靶点介导药物处置模型对抗CD47抗体进行模型引导的最佳给药
Clin Transl Sci. 2025 Aug;18(8):e70321. doi: 10.1111/cts.70321.
2
Translational minimal physiologically based pharmacokinetic model for transferrin receptor-mediated brain delivery of antibodies.用于转铁蛋白受体介导的抗体脑内递送的转化型最小生理药代动力学模型
MAbs. 2025 Dec;17(1):2515414. doi: 10.1080/19420862.2025.2515414. Epub 2025 Jun 26.
3
Leveraging neonatal Fc receptor (FcRn) to enhance antibody transport across the blood brain barrier.利用新生儿Fc受体(FcRn)增强抗体穿越血脑屏障的转运。
Nat Commun. 2025 May 3;16(1):4143. doi: 10.1038/s41467-025-59447-1.
4
Engineering FcRn binding kinetics dramatically extends antibody serum half-life and enhances therapeutic potential.工程化改造FcRn结合动力学可显著延长抗体血清半衰期并增强治疗潜力。
J Biol Eng. 2025 Apr 18;19(1):35. doi: 10.1186/s13036-025-00506-y.
5
Efgartigimod versus intravenous immunoglobulin in the treatment of patients with impending myasthenic crisis.依氟鸟氨酸治疗即将发生肌无力危象的患者:与静脉注射免疫球蛋白的对比。
Sci Rep. 2024 Nov 18;14(1):28394. doi: 10.1038/s41598-024-79918-7.
6
Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflows.评估和整合体外相关性以获得抗体可开发性工作流程中的药代动力学结果。
MAbs. 2024 Jan-Dec;16(1):2384104. doi: 10.1080/19420862.2024.2384104. Epub 2024 Jul 31.
7
Rapid depletion of "catch-and-release" anti-ASGR1 antibody in vivo.体内“捕捉-释放”抗 ASGR1 抗体的快速耗竭。
MAbs. 2024 Jan-Dec;16(1):2383013. doi: 10.1080/19420862.2024.2383013. Epub 2024 Jul 25.
8
In vivo mRNA expression of a multi-mechanistic mAb combination protects against Staphylococcus aureus infection.一种多机制单克隆抗体组合的体内mRNA表达可预防金黄色葡萄球菌感染。
Mol Ther. 2024 Aug 7;32(8):2505-2518. doi: 10.1016/j.ymthe.2024.05.036. Epub 2024 May 31.
9
Impact of structural modifications of IgG antibodies on effector functions.IgG 抗体结构修饰对效应功能的影响。
Front Immunol. 2024 Jan 8;14:1304365. doi: 10.3389/fimmu.2023.1304365. eCollection 2023.
10
Engineered serum markers for non-invasive monitoring of gene expression in the brain.用于无创监测大脑中基因表达的工程化血清标志物。
Nat Biotechnol. 2024 Nov;42(11):1717-1725. doi: 10.1038/s41587-023-02087-x. Epub 2024 Jan 10.

本文引用的文献

1
Structural insights into neonatal Fc receptor-based recycling mechanisms.基于新生儿 Fc 受体的内吞循环机制的结构研究进展
J Biol Chem. 2014 Mar 14;289(11):7812-24. doi: 10.1074/jbc.M113.537563. Epub 2014 Jan 27.
2
Crystal structure of an HSA/FcRn complex reveals recycling by competitive mimicry of HSA ligands at a pH-dependent hydrophobic interface.HSA/FcRn 复合物的晶体结构揭示了在 pH 依赖性疏水性界面处通过竞争性模拟 HSA 配体进行的再循环。
Structure. 2013 Nov 5;21(11):1966-78. doi: 10.1016/j.str.2013.08.022. Epub 2013 Oct 10.
3
A novel investigational Fc-modified humanized monoclonal antibody, motavizumab-YTE, has an extended half-life in healthy adults.一种新型的研究性Fc修饰人源化单克隆抗体莫他维izumab-YTE在健康成年人中具有延长的半衰期。
Antimicrob Agents Chemother. 2013 Dec;57(12):6147-53. doi: 10.1128/AAC.01285-13. Epub 2013 Sep 30.
4
Engineered monoclonal antibody with novel antigen-sweeping activity in vivo.体内具有新型抗原清扫活性的工程化单克隆抗体。
PLoS One. 2013 May 7;8(5):e63236. doi: 10.1371/journal.pone.0063236. Print 2013.
5
FcRn affinity-pharmacokinetic relationship of five human IgG4 antibodies engineered for improved in vitro FcRn binding properties in cynomolgus monkeys.在食蟹猴中,五种人源 IgG4 抗体经过工程改造以提高体外 FcRn 结合特性,其 FcRn 亲和力-药代动力学关系。
Drug Metab Dispos. 2012 Aug;40(8):1545-55. doi: 10.1124/dmd.112.045864. Epub 2012 May 14.
6
Monoclonal antibodies with identical Fc sequences can bind to FcRn differentially with pharmacokinetic consequences.具有相同 Fc 序列的单克隆抗体可以与 FcRn 以不同的方式结合,从而产生药代动力学后果。
Drug Metab Dispos. 2011 Sep;39(9):1469-77. doi: 10.1124/dmd.111.039453. Epub 2011 May 24.
7
Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization.工程化的 pH 依赖性抗原结合实现抗体回收,延长抗原中和的持续时间。
Nat Biotechnol. 2010 Nov;28(11):1203-7. doi: 10.1038/nbt.1691. Epub 2010 Oct 17.
8
A therapeutic anti-VEGF antibody with increased potency independent of pharmacokinetic half-life.一种具有增强效力的治疗性抗 VEGF 抗体,与药代动力学半衰期无关。
Cancer Res. 2010 Apr 15;70(8):3269-77. doi: 10.1158/0008-5472.CAN-09-4580. Epub 2010 Mar 30.
9
Reduced elimination of IgG antibodies by engineering the variable region.通过工程化改造可变区来减少 IgG 抗体的清除。
Protein Eng Des Sel. 2010 May;23(5):385-92. doi: 10.1093/protein/gzq009. Epub 2010 Feb 15.
10
Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.新生儿 FcR 在调节含有人 IgG1 Fc 结构域的治疗性蛋白血清半衰期中的重要性:单克隆抗体和 Fc 融合蛋白与人新生儿 FcR 亲和力的比较研究。
J Immunol. 2010 Feb 15;184(4):1968-76. doi: 10.4049/jimmunol.0903296. Epub 2010 Jan 18.